Allergan reports Q2 revenues of $4B — 5 insights

Allergan reported second quarter fiscal year 2017 revenues of $4 billion on Aug. 8.

Here's what you should know:

1. The company reported a 9 percent growth in year-over-year revenue.

2. Allergan posted net generally accepted accounting principle operating income of $1.9 billion, a 1.6 percent year-over-year increase.

3. Allergan's Botox drove second quarter sales.

4. Concerning its gastrointestinal sector, Allergan's Linzess led the quartet of products with $167.8 million in revenues. Asacol/Delzicol revenues decreased 61.9 percent year-over-year to $45.6 million.

5. Concerning rest-of-year outlooks, Allergan expects net revenues between $15.85 billion and $16.05 billion.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast